70. Spinal stenosis Clinical trials / Disease details
Clinical trials : 96 / Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05029726 (ClinicalTrials.gov) | September 2021 | 14/8/2021 | Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery | Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Management for Minimally Invasive (MIS) Lumbar Spine Surgery | Lumbar Spinal Stenosis;Lumbar Disc Herniation;Lumbar Spondylolisthesis;Lumbar Spondylosis;Lumbar Radiculopathy;Lumbar Spine Instability;Synovial Cyst;Degenerative Disc Disease;Degenerative Spondylolisthesis;Degenerative Intervertebral Discs | Drug: Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine;Drug: normal saline | John O'Toole | NULL | Not yet recruiting | 18 Years | 75 Years | All | 125 | Phase 4 | United States |